Archive
Every story, newest first.
Monday, November 2, 2026
Life Sciences
The MHRA has extended the UK authorisation of Casgevy, the CRISPR gene editing therapy from Vertex and CRISPR Therapeutics, to children aged five and over with severe sickle cell disease and transfusion dependent beta thalassaemia, down from age 12.
Life Sciences
Kymera Therapeutics has completed the 16 week placebo controlled portion of its BROADEN2 Phase 2b trial of oral STAT6 degrader KT-621 in eczema and expects results before the end of 2026, with 98 percent of eligible patients entering the open label extension and about 1.6 billion dollars of cash on hand.
Life Sciences
IDEXX Laboratories reported third quarter revenue of 1,214 million dollars, up 10 percent, with earnings per share of 4.01 dollars, up 18 percent, and raised its 2026 revenue guidance by 32 million dollars at the midpoint.
Life Sciences
Ferring Pharmaceuticals agreed on October 27 to acquire fertility company Gameto in a transaction worth up to 1.3825 billion dollars, with the value tied to development, regulatory and commercial milestones and no upfront payment disclosed.
Mining
Mining shares fell about five percent across every complex in the last session, with silver miners down 5.58 percent and uranium miners down 5.57 percent, even as silver futures settled 2.36 percent higher at 50.26 dollars an ounce.
Mining
Lotus Resources has dispatched its first uranium shipment from the restarted Kayelekera mine in Malawi, four containers holding about 145,000 pounds of U3O8 bound for Orano's Malvesi conversion plant in France.
Mining
Iron ore ticked up on Monday, with the Singapore December contract up 0.61 percent to 91.30 dollars a tonne, after Chinese hot metal output fell only 0.2 percent on the week to about 2.32 million tonnes a day.
Mining
Hancock Prospecting reported net profit after tax of 2.79 billion Australian dollars for the year to June 30, 2026, down from 3.08 billion, on revenue of 11.67 billion, while its Hancock Iron Ore business produced 71.5 million tonnes in its first consolidated year.
Mining
Citigroup cut its three month lithium carbonate price target by 40 percent to 12,000 dollars a tonne from 20,000 dollars, citing slowing battery demand growth, trade uncertainty and destocking.
Mining
BMC Minerals' updated feasibility study for Kudz Ze Kayah in Yukon puts after tax net present value at 1.7 billion dollars with a 54 percent internal rate of return and a 1.4 year payback, on an unchanged ore reserve.